Institut de Pharmacologie Moléculaire et Cellulaire et Institut de NeuroMédecine Moléculaire, UMR6097 CNRS/UNSA, Valbonne, France.
Neurodegener Dis. 2010;7(1-3):50-5. doi: 10.1159/000283483. Epub 2010 Feb 13.
Amyloid beta-peptides is the generic term for a set of hydrophobic peptides that accumulate in Alzheimer's disease (AD)-affected brains. These amyloid-beta peptide fragments are mainly generated by an enzymatic machinery referred to as gamma-secretase complex that is built up by the association of four distinct proteins, namely presenilin 1 (PS1) or PS2, nicastrin, Aph-1 and Pen-2. AD is also characterized by exacerbated cell death that appears linked to the tumor suppressor p53. Interestingly, all members of the gamma-secretase complex control p53-dependent cell death. On the other hand, p53 appears to be able to regulate directly or indirectly the expression and transcription of PS1, PS2 and Pen-2. This review will focus on the functional cross-talk between the members of the gamma-secretase complex and p53 and will discuss the putative implication of this oncogene in AD pathology.
淀粉样 β 肽是一组在阿尔茨海默病 (AD) 相关大脑中积累的疏水性肽的通用术语。这些淀粉样 β 肽片段主要由一种称为 γ-分泌酶复合物的酶促机制产生,该复合物由四个不同的蛋白质组成,即早老素 1 (PS1) 或 PS2、尼卡斯特林、Aph-1 和 Pen-2。AD 还表现出细胞死亡加剧,这似乎与肿瘤抑制因子 p53 有关。有趣的是,γ-分泌酶复合物的所有成员都控制着 p53 依赖性细胞死亡。另一方面,p53 似乎能够直接或间接调节 PS1、PS2 和 Pen-2 的表达和转录。这篇综述将重点讨论 γ-分泌酶复合物成员与 p53 之间的功能串扰,并讨论该癌基因在 AD 病理中的潜在意义。